Ben-Sasson Shmuel Projects

Results found (8)
No.CategoryTechnology NameBriefcaseLead Researcher
2115
  Category Medical Sciences, Peptide proteinHighlights Increased blood vessel permeability and vascular leak are a final common pathway in severe influenza and other fatal diseases, such as MERS, Ebola and sepsis. A novel biologics therapy ...
More
Ben-Sasson Shmuel
467
Mechanism-Based Anti-Angiogenic Drug-Combination to Treat Cancer Tiltan Pharma is a start up company that developed a novel treatment for cancer which is now at  a phase-II clinical study in metastatic pancreatic cancer. The company has ...
More
Ben-Sasson Shmuel
3167
  Category Life Sciences and Biotechnology    Keywords Type 2 Diabetes, Peptide, Insulin, Fatty liver, Glucose. Current development stage TRL3 Experimental proof of concept       Our Innovation Based on a provocative working hypothesis, ...
More
Ben-Sasson Shmuel
2894
 About the company Raziel Therapeutics is a clinical-stage pharmaceutical company developing a proprietary drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into thermogenic, brown-like adipose ...
More
Ben-Sasson Shmuel
4576
 Category Category Life Sciences and Biotechnology    Keywords Mitophagy restoration, age-related diseases Current development stage Initial POC demonstrated   Application Mitophagy is a mitochondrial-recycling cell mechanism which is ...
More
Ben-Sasson Shmuel
2338
  A non-invasive alternative to injection, by enhancing gastric absorption   Categories Oral drug-delivery, non-invasive drug administration, gastric absorption, peptide oral formulation, tight junctions (TJs), biopharmaceutical drugs, oral ...
More
Ben-Sasson Shmuel
574
Category Life Sciences and Bio Technology    Keywords G-protein coupled receptorsApplication One of the largest families of receptors in the human genome is that of the 7 transmembrane receptor (7-TMR) superfamily, also known as G-protein ...
More
Ben-Sasson Shmuel
4511
  Keywords Epigenetics, Dual-specificity, Enzymes, anti-cancer Current Development Stage TRL3 - Hypothesis testing and initial POC demonstrated Application Cancer cells lose their epigenetic checks and balances followed by unscheduled ...
More
Ben-Sasson Shmuel